Matches in SemOpenAlex for { <https://semopenalex.org/work/W2325062837> ?p ?o ?g. }
- W2325062837 endingPage "1194" @default.
- W2325062837 startingPage "1187" @default.
- W2325062837 abstract "Pancytopenia is a frequent manifestation of myelodysplastic syndromes (MDS). In the presence of an empty bone marrow, clinical distinction from aplastic anemia may be difficult. The hypoplastic marrow morphology seen in some cases of MDS raises questions about etiologic and pathophysiologic relationships between aplastic anemia and MDS. The goal of our study was to compare the degree of the hematopoietic failure in these diseases at the level of the most immature progenitor and stem cells that can be measured in vitro. In a systemic, prospective fashion, we have studied bone marrow (n = 45) and peripheral blood (n = 33) of patients with MDS for the number of long-term culture initiating cells (LTC-IC) in comparison to 17 normal controls and patients with new, untreated aplastic anemia (46 marrow; 62 blood samples). Due to the low numbers of cells available for the analysis, formal limiting dilution analysis could not be performed, instead secondary colony-forming cells (CFC) after 5 weeks of LTBMC were measured. As the number of these cells is proportional to the input number of LTC-IC, the number of secondary CFC per 106 mononuclear cells (MNC) initiating the LTBMC can be used as a measure of the content of immature stem cells in bone marrow and peripheral blood. The MDS group consisted of 34 RA, three RARS, eight RAEB and two RAEB-T patients with mean absolute neutrophil values of 1992, 1413, 1441, and 380 per mm3, respectively. The diagnosis was established based on bone marrow morphology and results of cytogenetic studies. In comparison to controls (147 ± 38/106 MNC), significantly decreased numbers of bone marrow secondary CFC were found in MDS: in patients with RA and RARS, 21 ± 7 secondary CFC per 106 bone marrow MNC (P < 0.001); patients with raeb and raeb-t: 39 ± 12 cfc per 106 marrow MNC (P < 0.001). in all groups tested, the decrease in peripheral blood secondary cfc numbers was consistently less pronounced. in mds patients with hypocellular bone marrow, secondary cfc were lower but not significantly different in comparison to mds with hypercellular marrow (18 ± 6 vs 35 ± 11; NS; hypoplastic bone marrow also was not associated with significantly lower neutrophil counts). However, in 24% of patients with MDS, bone marrow secondary CFC were within the normal range, while in the aplastic anemia group only one of the patients showed secondary CFC number within normal range. Bone marrow and blood secondary CFC numbers in hypoplastic RA were significantly higher than those in severe aplastic anemia 919 ± 5 in bone marrow, P < 0.01; 7 ± 2 in blood, P < 0.05). this trend was even more pronounced in hypoplastic ra with chromosomal abnormalities. however, no significant differences were found between the secondary cfc numbers in hypoplastic ra and moderate aplastic anemia. we concluded that, although the deficiency in the stem cell compartment is less severe in mds than in aplastic anemia, depletion of early hematopoietic cells is an essential part of the pathophysiology in both diseases." @default.
- W2325062837 created "2016-06-24" @default.
- W2325062837 creator A5003602297 @default.
- W2325062837 creator A5003951580 @default.
- W2325062837 creator A5026122857 @default.
- W2325062837 creator A5036236322 @default.
- W2325062837 creator A5052859085 @default.
- W2325062837 date "1998-08-01" @default.
- W2325062837 modified "2023-10-12" @default.
- W2325062837 title "Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome" @default.
- W2325062837 cites W1494325974 @default.
- W2325062837 cites W1497507796 @default.
- W2325062837 cites W155436811 @default.
- W2325062837 cites W168630383 @default.
- W2325062837 cites W193879736 @default.
- W2325062837 cites W196567407 @default.
- W2325062837 cites W1970022901 @default.
- W2325062837 cites W1974919527 @default.
- W2325062837 cites W1976709726 @default.
- W2325062837 cites W1980434141 @default.
- W2325062837 cites W1986014879 @default.
- W2325062837 cites W1993034272 @default.
- W2325062837 cites W2011548691 @default.
- W2325062837 cites W2014514378 @default.
- W2325062837 cites W2023882916 @default.
- W2325062837 cites W2038123436 @default.
- W2325062837 cites W2046619517 @default.
- W2325062837 cites W2047223210 @default.
- W2325062837 cites W2056972582 @default.
- W2325062837 cites W2066287497 @default.
- W2325062837 cites W2072617251 @default.
- W2325062837 cites W2080562823 @default.
- W2325062837 cites W2083048416 @default.
- W2325062837 cites W2086392106 @default.
- W2325062837 cites W2106620775 @default.
- W2325062837 cites W2127293420 @default.
- W2325062837 cites W2270227665 @default.
- W2325062837 cites W2296799275 @default.
- W2325062837 cites W2406368913 @default.
- W2325062837 cites W2409917906 @default.
- W2325062837 cites W2413443307 @default.
- W2325062837 cites W2414097276 @default.
- W2325062837 cites W2416422794 @default.
- W2325062837 cites W2419384495 @default.
- W2325062837 cites W2434609641 @default.
- W2325062837 cites W2474648652 @default.
- W2325062837 cites W27985177 @default.
- W2325062837 cites W2993163267 @default.
- W2325062837 cites W42365234 @default.
- W2325062837 cites W579135650 @default.
- W2325062837 cites W60749078 @default.
- W2325062837 cites W64588397 @default.
- W2325062837 cites W79010973 @default.
- W2325062837 cites W1967134545 @default.
- W2325062837 cites W1983392832 @default.
- W2325062837 cites W2415453968 @default.
- W2325062837 cites W2886345930 @default.
- W2325062837 doi "https://doi.org/10.1038/sj.leu.2401084" @default.
- W2325062837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9697872" @default.
- W2325062837 hasPublicationYear "1998" @default.
- W2325062837 type Work @default.
- W2325062837 sameAs 2325062837 @default.
- W2325062837 citedByCount "44" @default.
- W2325062837 countsByYear W23250628372013 @default.
- W2325062837 countsByYear W23250628372014 @default.
- W2325062837 countsByYear W23250628372015 @default.
- W2325062837 countsByYear W23250628372017 @default.
- W2325062837 countsByYear W23250628372019 @default.
- W2325062837 countsByYear W23250628372021 @default.
- W2325062837 countsByYear W23250628372022 @default.
- W2325062837 crossrefType "journal-article" @default.
- W2325062837 hasAuthorship W2325062837A5003602297 @default.
- W2325062837 hasAuthorship W2325062837A5003951580 @default.
- W2325062837 hasAuthorship W2325062837A5026122857 @default.
- W2325062837 hasAuthorship W2325062837A5036236322 @default.
- W2325062837 hasAuthorship W2325062837A5052859085 @default.
- W2325062837 hasBestOaLocation W23250628371 @default.
- W2325062837 hasConcept C109159458 @default.
- W2325062837 hasConcept C126322002 @default.
- W2325062837 hasConcept C137061746 @default.
- W2325062837 hasConcept C142724271 @default.
- W2325062837 hasConcept C201750760 @default.
- W2325062837 hasConcept C202751555 @default.
- W2325062837 hasConcept C203014093 @default.
- W2325062837 hasConcept C2778248108 @default.
- W2325062837 hasConcept C2779382419 @default.
- W2325062837 hasConcept C2780007613 @default.
- W2325062837 hasConcept C2780525284 @default.
- W2325062837 hasConcept C2780817109 @default.
- W2325062837 hasConcept C2781440808 @default.
- W2325062837 hasConcept C28328180 @default.
- W2325062837 hasConcept C54355233 @default.
- W2325062837 hasConcept C55493867 @default.
- W2325062837 hasConcept C71924100 @default.
- W2325062837 hasConcept C86803240 @default.
- W2325062837 hasConcept C90924648 @default.
- W2325062837 hasConceptScore W2325062837C109159458 @default.
- W2325062837 hasConceptScore W2325062837C126322002 @default.